BCH rose 28.78% in 24 hours after a planned regulated futures launch, while USD 1.37B turnover and stretched momentum raise reversal risk.

AURORA rose 118.45% in 24 hours as volume reached USD 45.94M, a high-turnover market-structure event after recent Aurora Intents activity.

Global oil stockpiles are being drawn down at a record pace, with the International Energy Agency estimating inventories have fallen by 507 million barrels since the conflict began. Disruptions have escalated as Ukrainian attacks have severely damaged Russia’s refining sector, which typically accounts for 4 per cent of global capacity, while China is preparing to lift crude imports. In Australia, average petrol prices have jumped nearly 40 per cent since July to above $2.30 a litre and diesel has risen nearly 60 per cent to $2.88, heightening concern about further increases.

MUBARAK gained 67.67% in 24 hours as USD 243.18 million turnover reached 3.24x market cap, signaling a selective meme-token rotation.

International oil prices fell for a sixth consecutive session, with Brent crude slipping below $100 a barrel to a more than two-week low. Reports said Saudi Arabia has restarted its east-west oil pipeline, lifting expectations of additional Middle East supply. Hopes for progress in negotiations between the United States and Iran also eased supply concerns and weighed on prices.

In its fiscal 2026 third-quarter earnings call summary, KB Home said housing demand remains weak and lowered its guidance for fourth-quarter average selling price and margins. The company forecast Q4 housing revenue of $1.45B$1.65B. It also said it plans share repurchases of up to $50M.

Novo Nordisk CEO Maziar Mike Doustdar said the company is open to a direct listing on the New York Stock Exchange to replace its existing American depositary receipts, the Financial Times reported. He said the move would reflect a shift in the company’s investor base over the past 20 years away from Scandinavia and toward the United States. Novo’s shares have fallen more than 70% from their peak, while Eli Lilly’s have risen. Lilly’s weight-loss drug Zepbound is expected to outsell Novo’s Wegovy this year by more than $7 billion.

Global wheat buyers are facing rising costs as the Russia-Ukraine war continues to squeeze exports from the Black Sea region. Russia’s September exports are expected to fall to 1 million tons and Ukraine’s to about 1 million tons, both roughly half of last year’s levels. Benchmark Chicago wheat futures have climbed 40% from June lows to a three-and-a-half-year high. Indonesian buyers have shifted to suppliers such as Argentina and Australia, paying 20% to 25% more than they previously paid for Black Sea wheat.